<DOC>
	<DOCNO>NCT00965744</DOCNO>
	<brief_summary>The aim trial verify efficiency new surgical device ( LigaSure vessel seal system ) esophagogastric decongestion splenectomy patient portal hypertension .</brief_summary>
	<brief_title>A Clinical Trial Vessel Sealing System ( LigaSure ) Azygoportal Disconnection Splenectomy Patients With Portal Hypertension</brief_title>
	<detailed_description>Bleeding esophageal gastric cardia varix major life threaten complication patient portal hypertension . Patients portal hypertension mortality rate 30 % -50 % first episode esophagogastric variceal rupture . The associated 1-year mortality rate report 75 % . The ideal treatment gastric varix effectively control bleed improve liver function optimum level . Although endoscopic treatment show great promise esophageal varix , still controversy regard treatment gastric varix . Hepatic encephalopathy remain dominant problem transjugular intrahepatic portosystemic shunt placement ( TIPS ) surgical shunt . A meta-analysis show incidence hepatic encephalopathy mortality increase significantly either nonselective selective shunt operation . Esophagogastric decongestion splenectomy without esophageal transaction fundamental operation perform department patient portal hypertension . Patients azygoportal devascularization method reveal reduction encephalopathy well diminished rebleeding rate . The crucial point procedure prevention brisk bleed dilated vessel like enlarged azygoportal collateral . Conventional hand-tied ligature become dislodged represent foreign body , important , tedious time-consuming . The LigaSure vessel seal system ( Valleylab , Boulder , Colorado ) bipolar electrosurgical device , seal vessel 7 mm diameter , denature collagen elastin within vessel wall surround connective tissue . This device test , excellent result , different field surgery ( gastrointestinal , hepatopancreatobiliary , urologic , gynecologic , laparoscopic , etc ) , demonstrate several recently publish study . Shamiyeh et al confirm reliability LigaSure closure vein laparoscopic azygoportal disconnection procedure portal hypertension porcine model 2005 , intra- post-operative bleeding conversion open surgery , 2 mm far thermal energy source , collateral damage solid tissue stomach could detect .</detailed_description>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Patients liver cirrhosis accompany portal hypertension secondary hypersplenism due hepatitis , alcoholic cirrhosis schistosomiasis , undergo elective azygoportal disconnection splenectomy Liver function ChildPugh C Hemoglobin &lt; 9 g/dL Ascites Abnormal coagulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Ligasure vessel seal system</keyword>
	<keyword>Azygoportal Disconnection</keyword>
	<keyword>Splenectomy</keyword>
	<keyword>Portal hypertension</keyword>
</DOC>